SCHEMBL23920929

SCHEMBL23920929

Cc1ccc(Sc2nc3c(=O)n4cc(-c5ccccc5)[nH]c4nc3n2CCO)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 8/20 0.46
ADORA1 P30542 2/20 0.46
ALDH1A1 P00352 3/20 0.41
GAA P10253 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
TP53 P04637 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
RXFP1 Q9HBX9 1/20 0.36
POLB P06746 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
LMNA P02545 2/20 0.33
PKM P14618 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
DHODH Q02127 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21396340 0.92 ADORA3 (0.45) ADORA3ADORA1ALDH1A1GAATDP1
SCHEMBL23920864 0.91 ADORA3 (0.45) ADORA3ADORA1ALDH1A1GAATDP1
SCHEMBL23920998 0.90 ADORA3 (0.48) ADORA3ADORA1ALDH1A1TDP1TP53
SCHEMBL21396458 0.90 ADORA3 (0.45) ADORA3ADORA1ALDH1A1GAATDP1
SCHEMBL23921237 0.89 ADORA3 (0.43) ADORA3ADORA1ALDH1A1GAATDP1
SCHEMBL23921009 0.89 ADORA3 (0.44) ADORA3ADORA1ALDH1A1GAATDP1
SCHEMBL23920938 0.89 ADORA3 (0.42) ADORA3ADORA1TDP1TP53MEN1
SCHEMBL23921233 0.87 ADORA3 (0.51) ADORA3ADORA1GAATDP1TP53
SCHEMBL23920866 0.85 ADORA3 (0.44) ADORA3ADORA1ALDH1A1GAATDP1
SCHEMBL23920978 0.85 ADORA3 (0.52) ADORA3ADORA1ALDH1A1GAATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242568-A1 POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES MIRECA MEDICINES GMBH (DE) 2023-08-03 US disclosed
US-20210317156-A1 NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES MIRECA MEDICINES GMBH (DE) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242568-A1 POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES PRKG1, PRKG2, PRKAG3 ADORA3 425/4885ADORA1 857/4885ALDH1A1 3952/4885
US-20210317156-A1 NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES PRKG1, PRKG2, PDE7A ADORA3 449/4885ADORA1 828/4885ALDH1A1 3981/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.